Terms: = Breast cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A
10223 results:
1. The use of longitudinal CT-based radiomics and clinicopathological features predicts the pathological complete response of metastasized axillary lymph nodes in breast cancer.
Wang J; Tian C; Zheng BJ; Zhang J; Jiao DC; Qu JR; Liu ZZ
BMC Cancer; 2024 May; 24(1):549. PubMed ID: 38693523
[TBL] [Abstract] [Full Text] [Related]
2. Study on the differential diagnosis of benign and malignant breast lesions using a deep learning model based on multimodal images.
Du Y; Wang D; Liu M; Zhang X; Ren W; Sun J; Yin C; Yang S; Zhang L
J Cancer Res Ther; 2024 Apr; 20(2):625-632. PubMed ID: 38687933
[TBL] [Abstract] [Full Text] [Related]
3. Doxorubicin, doxorubicinol, cardiotoxicity, breast cancer, volumetric absorptive microsampling, LC-MS/MS.
Chairunnisa DF; Harahap Y; Juanita M; Syafhan NF; Purwanto DJ
Pak J Biol Sci; 2024 Mar; 27(3):125-131. PubMed ID: 38686734
[TBL] [Abstract] [Full Text] [Related]
4. A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy.
Ascheid D; Baumann M; Pinnecker J; Friedrich M; Szi-Marton D; Medved C; Bundalo M; Ortmann V; Öztürk A; Nandigama R; Hemmen K; Ergün S; Zernecke A; Hirth M; Heinze KG; Henke E
Nat Commun; 2024 Apr; 15(1):3599. PubMed ID: 38678014
[TBL] [Abstract] [Full Text] [Related]
5. Synthesis and Validation of TRIFAPYs as a Family of Transfection Agents for Therapeutic Oligonucleotides.
Isanta B; Delgado A; Ciudad CJ; Busquets MA; Griera R; Llor N; Noé V
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672408
[TBL] [Abstract] [Full Text] [Related]
6. Stable feature selection utilizing Graph Convolutional Neural Network and Layer-wise Relevance Propagation for biomarker discovery in breast cancer.
Chereda H; Leha A; Beißbarth T
Artif Intell Med; 2024 May; 151():102840. PubMed ID: 38658129
[TBL] [Abstract] [Full Text] [Related]
7. Exploring a repurposed candidate with dual hIDO1/hTDO2 inhibitory potential for anticancer efficacy identified through pharmacophore-based virtual screening and in vitro evaluation.
Aboomar NM; Essam O; Hassan A; Bassiouny AR; Arafa RK
Sci Rep; 2024 Apr; 14(1):9386. PubMed ID: 38653790
[TBL] [Abstract] [Full Text] [Related]
8. Impact of Early Access Reform on Oncology Innovation in France: Approvals, Patients, and Costs.
Martin T; Rioufol C; Favier B; Martelli N; Madelaine I; Chouaid C; Borget I
BioDrugs; 2024 May; 38(3):465-475. PubMed ID: 38643301
[TBL] [Abstract] [Full Text] [Related]
9. Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project.
Potter S; Avery K; Ahmed R; de Boniface J; Chatterjee S; Dodwell D; Dubsky P; Iwata H; Jiang M; Lee HB; MacKenzie M; Poulakaki F; Richardson AL; Sepulveda K; Spillane A; Thompson AM; Werutsky G; Wright JL; Zdenkowski N; Cowan K; McIntosh S
BMJ Open; 2024 Apr; 14(4):e084488. PubMed ID: 38643011
[TBL] [Abstract] [Full Text] [Related]
10. Predisposing deleterious variants in the cancer-associated human kinases in the global populations.
Khan SA; Anwar M; Gohar A; Roosan MR; Hoessli DC; Khatoon A; Shakeel M
PLoS One; 2024; 19(4):e0298747. PubMed ID: 38635549
[TBL] [Abstract] [Full Text] [Related]
11. Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment.
Liu L; Zhang M; Cui N; Liu W; Di G; Wang Y; Xi X; Li H; Shen Z; Gu M; Wang Z; Jiang S; Liu B
PLoS One; 2024; 19(4):e0298004. PubMed ID: 38635528
[TBL] [Abstract] [Full Text] [Related]
12. Diet quality and cardiovascular disease risk among breast cancer survivors in the Pathways Study.
Ergas IJ; Cheng RK; Roh JM; Kushi LH; Kresovich JK; Iribarren C; Nguyen-Huynh M; Rana JS; Rillamas-Sun E; Laurent CA; Lee VS; Quesenberry CP; Greenlee H; Kwan ML
JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38627946
[TBL] [Abstract] [Full Text] [Related]
13. BRCA2 Polymorphisms and breast cancer Susceptibility: a Multi-Tools Bioinformatics Approach.
Jan H; Khan NU; Al-Qaaneh AM; Tasleem M; Almutairi MH; Ali I
Cell Physiol Biochem; 2024 Mar; 58(2):128-143. PubMed ID: 38623065
[TBL] [Abstract] [Full Text] [Related]
14. An improved breast cancer classification with hybrid chaotic sand cat and Remora Optimization feature selection algorithm.
Alhassan AM
PLoS One; 2024; 19(4):e0300622. PubMed ID: 38603682
[TBL] [Abstract] [Full Text] [Related]
15. Promoting the Anticancer Activity with Multidentate Furan-2-Carboxamide Functionalized Aroyl Thiourea Chelation in Binuclear Half-Sandwich Ruthenium(II) Complexes.
Thangavel SK; Mohamed Kasim MS; Rengan R
Inorg Chem; 2024 Apr; 63(16):7520-7539. PubMed ID: 38590210
[TBL] [Abstract] [Full Text] [Related]
16. Public data homogenization for AI model development in breast cancer.
Kilintzis V; Kalokyri V; Kondylakis H; Joshi S; Nikiforaki K; Díaz O; Lekadir K; Tsiknakis M; Marias K
Eur Radiol Exp; 2024 Apr; 8(1):42. PubMed ID: 38589742
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensive bioinformatics analysis unveils THEMIS2 as a carcinogenic indicator related to immune infiltration and prognosis of thyroid cancer.
Liu JF; Zou B; Xiang C; Yan HC
Sci Rep; 2024 Apr; 14(1):8156. PubMed ID: 38589421
[TBL] [Abstract] [Full Text] [Related]
18. Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
Alaeikhanehshir S; Voets MM; van Duijnhoven FH; Lips EH; Groen EJ; van Oirsouw MCJ; Hwang SE; Lo JY; Wesseling J; Mann RM; Teuwen J;
Cancer Imaging; 2024 Apr; 24(1):48. PubMed ID: 38576031
[TBL] [Abstract] [Full Text] [Related]
19. Pathogenic variants in human DNA damage repair genes mostly arose in recent human history.
Zhao B; Li J; Sinha S; Qin Z; Kou SH; Xiao F; Lei H; Chen T; Cao W; Ding X; Wang SM
BMC Cancer; 2024 Apr; 24(1):415. PubMed ID: 38575974
[TBL] [Abstract] [Full Text] [Related]
20. Development and validation of a model and nomogram for breast cancer diagnosis based on quantitative analysis of serum disease-specific haptoglobin N-glycosylation.
Li L; Xu Y; Lai Z; Li D; Sun Q; Li Z; Zhou Y
J Transl Med; 2024 Apr; 22(1):331. PubMed ID: 38575942
[TBL] [Abstract] [Full Text] [Related]
[Next]
